MPs to grill Pfizer chiefs over bid for AstraZeneca

Senior executives at Pfizer and the Takeover Panel will be summoned to face MPs as fears grow over the US drug maker's $100bn (£59bn) tilt for AstraZeneca.

Members of the Business Select Committee are worried that Pfizer's attempt to create the world's pre-eminent pharmaceuticals company will see another British "crown jewel" fall into foreign hands. A deal would be the biggest foreign takeover of a British company.

The committee's chairman, Adrian Bailey, said that launching an inquiry into the bid would be on the committee's agenda at its next meeting next week.

"This really highlights the need of the Takeover Panel to highlight public interest [with foreign takeovers]," he said. "AstraZeneca operates in an area where the UK has a global standing."

Another committee member, Brian Binley, told The Independent: "My concerns go back to Cadbury [and its takeover by US cheese maker Kraft]. There are certain jewels in the crown of British commerce and we will be talking about this."

The MPs' intervention came as Pfizer's chief executive, Ian Read, flew into the UK yesterday for a push to win over Astra's investors and the Government.

AstraZeneca's investors have signalled that Pfizer will have to pay $105bn-$110bn and increase the proportion of cash in its offer to win them over. The company has already said that $100bn falls "significantly" short of its expectations and has not entered into formal discussions with Pfizer.

Under UK takeover rules, the US company has until 26 May to table a formal bid to investors or walk away.

Pfizer, who shut its Kent plant in 2011 with 2,400 jobs losses, has already contacted the Government about its plans in an attempt to forestall a political backlash. Last night Mr Read, who studied in London in the 1970s, was reported to have issued a stark warning against any Government block on its bid.

"The UK faces a choice," he told the Financial Times. "Do they focus on ensuring there is an educated workforce with the right incentives to attract investment or do they pick winners and losers?"

The pharmaceuticals sector has been a hive of activity in recent weeks, with GlaxoSmithKline selling its cancer drugs business to Novartis last week and the Swiss company's vaccines unit going in the opposite direction.But one deal that looks less likely to happen is a tie-up between the US botox maker Allergan and FTSE 100 company Shire. Shire shares initally jumped yesterday amid speculation Allergan could bid for the UK group, but they ended down 1 per cent on reports the US group is now looking to sell itself to a potential white knight such as France's Sanofi, Johnson & Johnson of the US or Germany's Bayer as it fights off a $47bn takeover bid from Valeant and the activist investor Bill Ackman.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
SPONSORED FEATURES
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Mortgage Administration Team Leader

Negotiable: Recruitment Genius: This company prides itself on its ability to p...

Recruitment Genius: Mortgage Advisor

Negotiable: Recruitment Genius: This company prides itself on its ability to p...

Ashdown Group: Solvency II Project Manager - 10 month contract - £800 p/d

£800 per day: Ashdown Group: A highly successful, global financial services co...

SThree: Trainee Recruitment Consulant

£20000 - £25000 per annum + competitive: SThree: SThree are a global FTSE 250...

Day In a Page

A Very British Coup, part two: New novel in pipeline as Jeremy Corbyn's rise inspires sequel

A Very British Coup, part two

New novel in pipeline as Jeremy Corbyn's rise inspires sequel
6 best recipe files

6 best recipe files

Get organised like a Bake Off champion and put all your show-stopping recipes in one place
Mullah Omar, creator of the Taliban, is dead... for the fourth time

Mullah Omar, creator of the Taliban, is dead... again

I was once told that intelligence services declare their enemies dead to provoke them into popping up their heads and revealing their location, says Robert Fisk
Margaret Attwood on climate change: 'Time is running out for our fragile, Goldilocks planet'

Margaret Atwood on climate change

The author looks back on what she wrote about oil in 2009, and reflects on how the conversation has changed in a mere six years
New Dr Seuss manuscript discovered: What Pet Should I Get? goes on sale this week

New Dr Seuss manuscript discovered

What Pet Should I Get? goes on sale this week
Oculus Rift and the lonely cartoon hedgehog who could become the first ever virtual reality movie star

The cartoon hedgehog leading the way into a whole new reality

Virtual reality is the 'next chapter' of entertainment. Tim Walker gives it a try
Ants have unique ability to switch between individual and collective action, says study

Secrets of ants' teamwork revealed

The insects have an almost unique ability to switch between individual and collective action
Donovan interview: The singer is releasing a greatest hits album to mark his 50th year in folk

Donovan marks his 50th year in folk

The singer tells Nick Duerden about receiving death threats, why the world is 'mentally ill', and how he can write a song about anything, from ecology to crumpets
Let's Race simulator: Ultra-realistic technology recreates thrill of the Formula One circuit

Simulator recreates thrill of F1 circuit

Rory Buckeridge gets behind the wheel and explains how it works
Twitter accused of 'Facebookisation' over plans to overhaul reverse-chronological timeline

Twitter accused of 'Facebookisation'

Facebook exasperates its users by deciding which posts they can and can’t see. So why has Twitter announced plans to do the same?
Jane Birkin asks Hermès to rename bag - but what else could the fashion house call it?

Jane Birkin asks Hermès to rename bag

The star was shocked by a Peta investigation into the exotic skins trade
10 best waterproof mascaras

Whatever the weather: 10 best waterproof mascaras

We found lash-enhancing beauties that won’t budge no matter what you throw at them
Diego Costa biography: Chelsea striker's route to the top - from those who shared his journey

Diego Costa: I go to war. You come with me...

Chelsea's rampaging striker had to fight his way from a poor city in Brazil to life at the top of the Premier League. A new book speaks to those who shared his journey
Ashes 2015: England show the mettle to strike back hard in third Test

England show the mettle to strike back hard in third Test

The biggest problem facing them in Birmingham was the recovery of the zeitgeist that drained so quickly under the weight of Australian runs at Lord's, says Kevin Garside
Women's Open 2015: Charley Hull - 'I know I'm a good golfer but I'm also just a person'

Charley Hull: 'I know I'm a good golfer but I'm also just a person'

British teen keeps her feet on ground ahead of Women's Open